Clinical Trials Browser

Phase 1/2 × Unknown × Ramucirumab × Clear all

NCT03995017 2023-02-01

RiME

Phase 1/2 Unknown

Gastrointestinal

Adenocarcinoma Of Esophagus, Adenocarcinoma, Stomach Neoplasms

NCT04888663 2021-05-21

Study of Ramucirumab, Trastuzumab and Paclitaxel in Patients With HER2-positive Recurrent/Metastatic Gastric Cancer (HER-RAM Study)

Phase 1/2 Unknown

Gastrointestinal

Stomach Neoplasms